Foster Wheeler Eastern Private Limited has been awarded an engineering, procurement, construction management and commissioning services contract by GlaxoSmithKline Biologicals for a new biotechnology production facility in Singapore.
The value of the contract was not disclosed. The engineering and procurement services were included in Foster Wheeler's first-quarter 2007 bookings and the construction management and commissioning services will be included in its third-quarter 2007 bookings.
The facility includes two production buildings, a quality control and administration building, and a utilities building, all on a site of more than 8.8 hectares in Tuas Biomedical Park, in Singapore.
IEA report shows nuclear sector booming despite costs
Delays, in the UK, over approval of nuclear, seem to be the major issue (such as for SMRs). The report is about market finance and does not address...